Eli Lilly said on Thursday the U.S. Food and Drug Administration has approved its treatment for a form of advanced breast cancer in adult patients who have received prior therapy.
The Food and Drug Administration will review evidence about the safety and efficacy of the abortion drug Mifepristone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback